Hide metadata

Elbasvir/Grazoprevir in Treatment of Hepatitis C Virus Infection in Patients Who Are Receiving Opioid Agonist Therapy (OAT): A Cost-Effectiveness Analysis

dc.contributor.authorCap, Phuong Pham Ngoc
dc.date.accessioned2017-10-06T22:27:39Z
dc.date.issued2017
dc.identifier.citationCap, Phuong Pham Ngoc. Elbasvir/Grazoprevir in Treatment of Hepatitis C Virus Infection in Patients Who Are Receiving Opioid Agonist Therapy (OAT): A Cost-Effectiveness Analysis. Master thesis, University of Oslo, 2017
dc.identifier.urihttp://hdl.handle.net/10852/58671
dc.description.abstracteng
dc.language.isoeng
dc.subject
dc.titleElbasvir/Grazoprevir in Treatment of Hepatitis C Virus Infection in Patients Who Are Receiving Opioid Agonist Therapy (OAT): A Cost-Effectiveness Analysiseng
dc.typeMaster thesis
dc.date.updated2017-10-06T22:27:39Z
dc.creator.authorCap, Phuong Pham Ngoc
dc.date.embargoenddate3017-06-30
dc.rights.termsDette dokumentet er ikke elektronisk tilgjengelig etter ønske fra forfatter. Tilgangskode/Access code A
dc.identifier.urnURN:NBN:no-61397
dc.type.documentMasteroppgave
dc.rights.accessrightsclosedaccess
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/58671/1/EUHEM-MASTER-THESIS-CAPPNP--final-.pdf


Files in this item

Name:
EUHEM-MASTER-THESIS-CAPPNP--fi ...
Size:
2.253Mb
Format:
application/
View/Open

Appears in the following Collection

Hide metadata